Literature DB >> 19822403

Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.

J de Bresser1, B de Vos, F van der Ent, K Hulsewé.   

Abstract

BACKGROUND: Axillary metastatic lymphadenopathy with no primary tumour identified in the breast on physical examination, mammography or ultrasound is referred to as occult breast cancer. The goal of this systematic review is to give an overview of the value and additional considerations of using breast MRI in occult breast cancer.
METHODS: The databases of Pubmed, Embase, CINAHL and the Cochrane library were searched for studies addressing the use of breast MRI in occult breast cancer. Cross-referencing was used to find additional articles.
RESULTS: 8 retrospective studies were included. Breast MRI can detect an otherwise occult breast cancer in more than two thirds of patients with a high sensitivity but lower specificity. In 80% of patients MRI detected lesions could be localized again by using ultrasound. Furthermore the size and localization of the lesions found on MRI most often correlated closely with findings at pathology. Breast MRI also provided the possibility of breast conserving surgery in one thirds of patients.
CONCLUSION: Breast MRI can result in additional detection of otherwise occult lesions in occult breast cancer. Because of low specificity of malignant lesion detection by breast MRI, lesions should be histologically confirmed. This can be achieved either by MRI or ultrasound guided biopsy, as long as all MRI detected lesions are histologically checked. Routine application of breast MRI in occult breast cancer may also alter locoregional treatment by offering the possibility of breast conserving surgery in one thirds of patients. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19822403     DOI: 10.1016/j.ejso.2009.09.007

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  20 in total

Review 1.  [Radiotherapeutic concepts in cancer of unknown primary site].

Authors:  D Krug; J Debus; F Sterzing
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

Review 2.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

3.  Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).

Authors:  Damian P McCartan; Emily C Zabor; Monica Morrow; Kimberly J Van Zee; Mahmoud B El-Tamer
Journal:  Ann Surg Oncol       Date:  2017-07-12       Impact factor: 5.344

4.  Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone.

Authors:  A V Chudgar; E F Conant; S P Weinstein; B M Keller; M Synnestvedt; P Yamartino; E S McDonald
Journal:  Clin Radiol       Date:  2017-03-17       Impact factor: 2.350

5.  [Radiological diagnostics in CUP syndrome].

Authors:  P M Kazmierczak; K Nikolaou; A Rominger; A Graser; M F Reiser; C C Cyran
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

6.  A simplified scoring protocol to improve diagnostic accuracy with the breast imaging reporting and data system in breast magnetic resonance imaging.

Authors:  Liuquan Cheng; Xiru Li; Yuting Zhong; Menglu Li; Jingjin Zhu; Boya Zhang; Mei Liu; Zhili Wang; Jiandong Wang; Yiqiong Zheng
Journal:  Quant Imaging Med Surg       Date:  2022-07

7.  Breast Cancer in the Elderly: Is MRI Helpful?

Authors:  Melissa Pilewskie; Allison Hirsch; Anne Eaton; Michelle Stempel; Mary L Gemignani
Journal:  Breast J       Date:  2015-09-24       Impact factor: 2.431

8.  Occult primary breast cancer at a comprehensive cancer center.

Authors:  Oluwadamilola M Fayanju; Donna B Jeffe; Julie A Margenthaler
Journal:  J Surg Res       Date:  2013-07-02       Impact factor: 2.192

9.  Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma.

Authors:  Thaer Khoury; Ana Lucia Ruano Mendez; Xuan Peng; Li Yan; Emilian Racila
Journal:  Int J Clin Oncol       Date:  2019-10-04       Impact factor: 3.402

10.  Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics.

Authors:  Nicole K Yun; Jessica A Slostad; Ankur Naqib; Casey Frankenberger; Claudia B Perez; Ritu Ghai; Lydia Usha
Journal:  Oncologist       Date:  2021-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.